Matthew Perrone

AP Health Writer focusing on medicine, money and policy.
Signal: MattLPerrone.82.
Sends tips, docs anonymously:

[Matthew Perrone @AP_FDAwriter]

More Americans are injecting themselves with unapproved peptides pitched as ways to build muscle, rejuvenate skin and extend life. The trend is popular among influencers and RFK Jr. allies, but experts are concerned about the risks and long-term safety.
https://t.co/7vN48MpMzT

[Matthew Perrone @AP_FDAwriter]

@AlecGaffney Congrats!

[Zach Brennan @ZacharyBrennan]

Califf on GLP-1 compounding:

[Matthew Perrone @AP_FDAwriter]

AP health reporter in the wild:
https://t.co/7yqM3aJkW5

[Matthew Perrone @AP_FDAwriter]

SCOOP: Fruit-flavored e-cigarettes recently OK'd by the FDA were not significantly better at helping smokers quit than tobacco-flavored ones, according to a new memo that’s likely to stir more questions about the controversial decision. https://t.co/oQfsj9uIKX

[Matthew Perrone @AP_FDAwriter]

Federal health regulators signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years, giving Americans access to a skin-protecting chemical long used in Europe and other parts of the world. https://t.co/M5CWODbM6j

[Jason Mast @Jasonmmast]

Acting commissioner Kyle Diamantis stands out among Trump-appointed FDA leaders by — wait for it —showing up prepared and earning the trust of staff

From @LizzyLaw_

https://t.co/5AnrhofWeW

[Matthew Perrone @AP_FDAwriter]

SCOOP: Senior FDA tobacco officials tasked with enforcing vaping regulations were not consulted on the new guidelines and only learned of them the night before they were published: https://t.co/3EmUpMHNhL

[Matthew Perrone @AP_FDAwriter]

https://t.co/Ff7uMzEiRl

[AP News Guild @APNewsGuild]

1/3
On May 15, Associated Press leadership cut 20 guild covered staff. Layoffs included U.S. news, photographers, investigations, business and sports across 12 states.

[Matthew Perrone @AP_FDAwriter]

@houseofbuddy So sorry Mark! Always enjoyed talking PA politics around election season. AP is lesser organization after today.

[The Associated Press @AP]

BREAKING: The Supreme Court preserves access to widely used abortion pill, mifepristone, while a lawsuit plays out. https://t.co/pBvrNJsNA1

[Matthew Perrone @AP_FDAwriter]

Whoever steps into the role on a permanent basis will inherit the same challenge that dogged Makary: balancing the anti-regulatory interests of Trump with the Kennedy's MAHA agenda, including scrutinizing the safety of food additives, drugs and vaccines.
https://t.co/v39jQY63jR

[Matthew Perrone @AP_FDAwriter]

@VaporTechAssoc on Makary ouster at FDA: "While our engagement with the Commissioner was brief, we believed he was beginning to recognize that the current system requires substantial reform and that progress is needed to move more quickly."

[Matthew Perrone @AP_FDAwriter]

Makary struggled to manage FDA’s bureaucracy and failed to win the confidence of its staff after mass layoffs, leadership upheavals and a series of controversies in which the agency’s scientific principles appeared to be overridden by political interests.
https://t.co/pOO2lEbRWZ

[Mike Catalini @mikecatalini]

Supreme Court temporarily extends women's access to a widely used abortion pill. By @shermancourt, @geoffmulvihill and @AP_FDAwriter
https://t.co/n8FNEEDU2h

[Saeed Ahmed @saeed_ahmed]

The @AP won the 2026 Pulitzer Prize for international reporting for an investigation into how American companies help lay the foundations of the Chinese government’s system for monitoring and policing its citizens.

[Seung Min Kim @seungminkim]

Please read our incredible media writer @dbauder's final piece in his illustrious career at the @AP:

A photographer has captured some 50 newsrooms to document places and lives endangered by the industry’s collapse https://t.co/m3BMELtZl9

[AP News Guild @APNewsGuild]

1/3

Today, 40 Associated Press guild-covered employees across the U.S. who accepted buyouts left the newsroom for the final time. We’ve been told layoffs will be coming, with no clear timeline.

In solidarity, our members in office, at home, and in the field wore their union red today.

[David Lim @davidalim]

Scooplet: Katherine Szarama has been elevated to be FDA acting director of the Center for Biologics Evaluation and Research, replacing outgoing former top vaccine regulator Vinay Prasad.

https://t.co/TjavU0uVOX

[Scott Gottlieb, MD 🇺🇸 @ScottGottliebMD]

My op ed in today's @WashPost - "Trump’s executive order on psychedelics strikes a healthy balance: The president preserved the FDA's role, even as some want the agency's gatekeeping dismantled."

https://t.co/9hH7kz107J